Health Care Provider Perspectives on Pre-exposure Prophylaxis

2019 ◽  
Vol 30 (6) ◽  
pp. 630-638 ◽  
Author(s):  
Sarahmona Przybyla ◽  
Susan LaValley ◽  
Noelle St. Vil
2011 ◽  
Vol 3 ◽  
pp. JCNSD.S4091 ◽  
Author(s):  
Heidi J. Wehring ◽  
Sheryl Thedford ◽  
Maju Koola ◽  
Deanna L. Kelly

Olanzapine long acting injection has joined risperidone and paliperidone as the second generation long acting antipsychotic injection options for treatment of patients with schizophrenia. Long acting injections are important alternatives to oral medications for patients who have difficulty adhering to daily or multiple daily medication administrations, yet may be underutilized or not well understood. Patient perceptions, adherence, and preferences are important issues for health care providers to address when discussing treatment options with their patients. Reviewed here are overall patient and health care provider attitudes and perceptions regarding long acting injections and the details of olanzapine long acting injectable, the newest agent, and how it will fit in the marketplace. In addition, efficacy, safety, dosing and use data regarding this newest long acting agent are reviewed and compared to other available long acting agents.


Sexual Health ◽  
2014 ◽  
Vol 11 (3) ◽  
pp. 244 ◽  
Author(s):  
Lisa A. Eaton ◽  
Daniel D. Driffin ◽  
Harlan Smith ◽  
Christopher Conway-Washington ◽  
Denise White ◽  
...  

Objectives In the US, Black men who have sex with men (BMSM) are disproportionately affected by HIV/AIDS. Pre-exposure prophylaxis (PrEP) holds tremendous promise for curbing the HIV/AIDS epidemic among these men. However, many psychosocial components must be addressed in order to implement this prevention tool effectively among BMSM. Methods: We assessed PrEP knowledge and use, health care access experiences, race-based medical mistrust, sexual partners and behaviours, and drug and alcohol use among 699 men attending a community event in the south-eastern United States. We used generalised linear modelling to assess factors associated with their willingness to use PrEP. Results: Three hundred and ninety-eight men reported being BMSM and having HIV-negative status. Among these men, 60% reported being willing to use PrEP. Lack of being comfortable with talking to a health care provider about having sex with men, not having discussed having sex with a man with a health care provider, race-based medical mistrust, and alcohol consumption and substance use were all identified as barriers to willingness to use PrEP. Sexual risk-taking, number of sex partners and STI diagnosis were not associated with willingness to use PrEP. Conclusions: Findings from the current paper demonstrate the importance of acknowledging the role of various psychosocial factors in the uptake of PrEP. It is imperative that we prioritise research into understanding these barriers better, as the failure to do so will impede the tremendous potential of this prevention technology.


2018 ◽  
Vol 32 ◽  
pp. 137-142 ◽  
Author(s):  
Pratima Murthy ◽  
B.N. Subodh ◽  
Dhirendra Sinha ◽  
Mira Aghi ◽  
Pankaj Chaturvedi

Autism ◽  
2016 ◽  
Vol 20 (8) ◽  
pp. 986-994 ◽  
Author(s):  
Barbara Muskat ◽  
Andrea Greenblatt ◽  
David B Nicholas ◽  
Savithiri Ratnapalan ◽  
Justine Cohen-Silver ◽  
...  

2018 ◽  
Vol 8 (7) ◽  
pp. 394-403 ◽  
Author(s):  
Arti D. Desai ◽  
Elizabeth A. Jacob-Files ◽  
Julia Wignall ◽  
Grace Wang ◽  
Wanda Pratt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document